Purchase Order HHSN261201800149P

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for $12,750.00 on November 9, 2018, with ultimate completion on November 9, 2019. Work is performed in Woburn, Massachusetts. The order is firm fixed price with no set-aside designation. Covaris is a small business concern specializing in genomic research equipment and sample preparation technologies utilizing proprietary Adaptive Focused Acoustics technology.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for $24,210.00 on June 16, 2020, with ultimate completion on June 17, 2021. The order covers laboratory supplies on a firm fixed-price basis with no set-aside designation. Performance takes place in Woburn, Massachusetts, where Covaris manufactures genomic research equipment and sample preparation technologies.</p>

The National Cancer Institute awarded a purchase order to Covaris, LLC valued at $9,750.00 on March 16, 2018, for genomic research equipment and technologies. No set-aside applied. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure and an ultimate completion date of April 20, 2019. Covaris manufactures advanced genomic research instruments utilizing proprietary Adaptive Focused Acoustics technology, serving federal research agencies with specialized...

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for a Covaris ME220 Focused Ultrasonicator for Chromatin and DNA Shearing valued at $55,513.00 on August 7, 2019. The order carries a Total Small Business set-aside designation. Performance occurs at Woburn, Massachusetts. The underlying solicitation was posted July 5, 2019, with a due date of July 12, 2019. Ultimate completion is scheduled for October 2, 2019. The contract is firm fixed price.</p>

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $17,400 purchase order to Covaris, LLC for maintenance services. Under the firm fixed price contract, Covaris will provide maintenance and support for laboratory equipment located at the agency's facilities in Bethesda, Maryland. The one-year agreement runs from January 2, 2024 through January 1, 2025. No subcontractors or set aside designations were identified. The National Cancer...

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for a one-year service plan covering LE220-PLUS equipment (serial number 3388 and WCS 5177) with a ceiling value of $17,255.00, awarded May 7, 2020, with performance through July 1, 2021. Place of performance is Woburn, Massachusetts. The order is firm-fixed-price with no set-aside designation. Covaris is a small business concern specializing in genomic research instrumentation and associated maintenance and...

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC valued at $21,833.00 on July 13, 2018, for genomic research equipment and technologies. Performance is located in North Bethesda, Maryland, with an ultimate completion date of August 12, 2018. The order is firm fixed price with no small business set-aside designation. Covaris manufactures specialized laboratory instrumentation including focused ultrasonicator instruments and associated accessories for DNA and...

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for maintenance of a Covaris E220 instrument located in Dr. Pedro Batista's lab at Bethesda, Maryland, with a ceiling value of $13,133.00 and an award date of November 7, 2019. The order is firm fixed price with an ultimate completion date of November 9, 2020. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for one E220 focused-ultrasonicator instrument valued at $132,195.00 on August 22, 2017. This is a Total Small Business set-aside, firm fixed-price acquisition. The ultrasonicator is procured for sample preparation and analysis at the National Cancer Institute facility in Rockville, Maryland. The order carries an ultimate completion date of October 17, 2017.</p>

This firm-fixed-price purchase order valued at $4,500 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic sample preparation instruments and accessories. The contract, which had no set-aside designation, was for the delivery of Covaris' ME220, M220, and LE220-plus focused-ultrasonicator systems and related maintenance services to support genomic...